The most active compound AK‐2292 effectively induced degradation of STAT5A, STAT5B, and phosphorylated STAT5 proteins in AML cells in a concentration‐ and time‐dependent manner, and exhibited excellent degradation selectivity for STAT5 over all other STAT members. The gene discussed is STAT5B; the disease is acute myeloid leukemia.